Photoangioplasty for human periphoseral atheroscleosis results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin) Academic Article uri icon

Overview

MeSH Major

  • Peripheral Vascular Diseases
  • Photochemotherapy
  • Photosensitizing Agents

abstract

  • This phase I study demonstrates that photoangioplasty with motexafin lutetium is well tolerated and safe. Preliminary efficacy data suggest a future role for the treatment of flow-limiting atherosclerosis.

publication date

  • November 7, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11067782

Additional Document Info

start page

  • 2322

end page

  • 4

volume

  • 102

number

  • 19 SUPPL.